VPS18 and Huntington disease: In order to investigate T cell activation following Pep3 treatment, in HD and type 1 diabetes PBMC, expression of the regulatory PD1 molecule was studied after 24 hrs treatment with the peptide and subsequent anti-CD3/CD28 stimulation.